Effect of MTAD on The Outcome of Primary Root Canal Treatment
Launched by CUKUROVA UNIVERSITY · Sep 22, 2022
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
This randomized controlled clinical trial was conducted to evaluate radiographic periapical repair after endodontic treatment using 5 mL of MTAD and 5 mL of distilled water (MTAD group) or 5 ml of 17% EDTA solution and 5 ml of distilled water (Control group) irrigation in single-rooted teeth with apical periodontitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No systemic diseases
- • No history of taking analgesics in the previous seven days or other drugs prior to presenting for treatment
- • All selected teeth were necrotic, single root teeth with a periapical lesion ( 2\>PAI ≤5 mm)
- Exclusion Criteria:
- • Systemic and/or periodontal disease
- • Allergy to local anesthetic agents and/or histrory of intolerance to nonsteroidal anti-inflammatory drugs;
- • Requirement for antibiotic prophylaxis
- • Open tooth apex
- • Pacemaker use
- • Women were pregnant or breastfeeding status
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials